-
Japan has pre-ordered COVID-19 vaccine doses for more than four times its population, says report
europeanpharmaceuticalreview
January 20, 2021
Japan has procurement deals with half of the companies leading the COVID-19 vaccine development race, according to GlobalData.
-
Switzerland authorises Moderna’s Covid-19 vaccine
pharmaceutical-technology
January 14, 2021
The Swiss Agency for Therapeutic Products, Swissmedic, has authorised the Moderna’s Covid-19 vaccine in Switzerland.
-
Moderna Covid-19 vaccine receives European Commission authorisation
pharmaceutical-technology
January 08, 2021
The European Commission has granted a conditional marketing authorisation (CMA) to COVID-19 Vaccine Moderna for active immunisation to prevent the disease in individuals aged 18 years and above.
-
Moderna in talks with South Korea to supply 40 million doses of Covid-19 vaccine
pharmaceutical-business-review
January 06, 2021
Biotechnology company Moderna is negotiating with the South Korean government to potentially provide 40 million or more doses of its vaccine against Covid-19.
-
Israel authorises import of Moderna’s Covid-19 vaccine
pharmaceutical-technology
January 06, 2021
The Israeli Ministry of Health (MOH) has granted authorisation to import Moderna’s Covid-19 vaccine in the country.
-
Moderna’s COVID-19 vaccine is 94 percent effective, according to trial results
europeanpharmaceuticalreview
January 05, 2021
Phase III trial data suggests the mRNA-1273 vaccine is safe and highly effective at preventing COVID-19 in adults.
-
US may halve doses of Moderna vaccine to speed rollout: Moncef Slaoui
expresspharma
January 05, 2021
Moncef Slaoui, Head of Operation Warp Speed, said that officials were in talks with Moderna and the Food and Drug Administration about the idea.
-
Recipharm, Moderna sign deal for manufacturing, fill-finish of COVID-19 vaccines
expresspharma
December 31, 2020
They have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 vaccine supply outside of the US.
-
US doctor develops severe allergic reaction to Moderna COVID-19 vaccine, reports NYT
expresspharma
December 28, 2020
It is the first severe reaction publicly linked to Moderna’s vaccine, which is in its first week of rollout in the US.
-
Moderna’s Covid-19 vaccine obtains Health Canada authorisation
pharmaceutical-technology
December 25, 2020
Moderna has received authorisation for its Covid-19 vaccine from Health Canada for the immunisation of individuals aged 18 years and above.